{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:16:06Z","timestamp":1787505366216,"version":"build-2736575974"},"reference-count":193,"publisher":"National Institute for Health and Care Research","issue":"82","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/non-commercial-government-licence\/non-commercial-government-licence.htm"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["12\/60\/01"],"award-info":[{"award-number":["12\/60\/01"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"<jats:sec id=\"abs1-1\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>High fractions of exhaled nitric oxide (FeNO) in the breath of patients with symptoms of asthma are correlated with high levels of eosinophils and indicate that a patient is likely to respond to inhaled corticosteroids. This may have a role in the diagnosis and management of asthma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-2\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To assess the diagnostic accuracy, clinical effectiveness and cost-effectiveness of the hand-held electrochemical devices NIOX MINO\n                      <jats:sup>\u00ae<\/jats:sup>\n                      (Aerocrine, Solna, Sweden), NIOX VERO\n                      <jats:sup>\u00ae<\/jats:sup>\n                      (Aerocrine) and NObreath\n                      <jats:sup>\u00ae<\/jats:sup>\n                      (Bedfont Scientific, Maidstone, UK) for the diagnosis and management of asthma.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-3\">\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>\n                      Systematic searches were carried out between March 2013 and April 2013 from database inception. Databases searched included MEDLINE, EMBASE, the Cochrane Database of Systematic Reviews, the Database of Abstracts of Reviews of Effects, Science Citation Index Expanded and Conference Proceedings Citation Index \u2013 Science. Trial registers such as ClinicalTrials.gov and the\n                      <jats:italic>meta<\/jats:italic>\n                      Register of Controlled Trials were also searched in March 2013. All searches were updated in September 2013.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-4\">\n                    <jats:title>Review methods<\/jats:title>\n                    <jats:p>A rapid review was conducted to assess the equivalence of hand-held and chemiluminescent FeNO monitors. Systematic reviews of diagnostic accuracy and management efficacy were conducted. A systematic review of economic analyses was also conducted and two de novo health economic models were developed. All three reviews were undertaken according to robust high-quality methodology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-5\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The rapid review (27 studies) found varying levels of agreement between monitors (Bland\u2013Altman 95% limits of agreement up to \u00b110\u2009parts per billion), with better agreement at lower FeNO values. Correlation was good (generally\n                      <jats:italic>r<\/jats:italic>\n                      \u2009&gt;\u20090.9). The diagnostic accuracy review identified 22 studies in adults (all ages) and four in children. No studies used NObreath or NIOX VERO and seven used NIOX MINO. Estimates of diagnostic accuracy varied widely. FeNO used in combination with another test altered diagnostic accuracy only slightly. High levels of heterogeneity precluded meta-analysis. Limited observations included that FeNO may be more reliable and useful as a rule-in than as a rule-out test; lower cut-off values in children and in smokers may be appropriate; and FeNO may be less reliable in the elderly. The management review identified five randomised controlled trials in adults, one in pregnant asthmatics and seven in children. Despite clinical heterogeneity, exacerbation rates were lower in all studies but not generally statistically significantly so. Effects on inhaled corticosteroid (ICS) use were inconsistent, possibly because of differences in management protocols, differential effectiveness in adults and children and differences in population severity. One UK diagnostic model and one management model were identified. Aerocrine also submitted diagnostic and management models. All had significant limitations including short time horizons and the selective use of efficacy evidence. The de novo diagnostic model suggested that the expected difference in quality-adjusted life-year (QALY) gains between diagnostic options is likely to be very small. Airway hyper-responsiveness by methacholine challenge test is expected to produce the greatest QALY gain but with an expected incremental cost-effectiveness ratio (ICER) compared with FeNO (NObreath) in combination with bronchodilator reversibility of \u00a31.125M per QALY gained. All remaining options are expected to be dominated. The de novo management model indicates that the ICER of guidelines plus FeNO monitoring using NObreath compared with guidelines alone in children is expected to be approximately \u00a345,200 per QALY gained. Within the adult subgroup, FeNO monitoring using NObreath compared with guidelines alone is expected to have an ICER of approximately \u00a32100 per QALY gained. The results are particularly sensitive to assumptions regarding changes in ICS use over time, the number of nurse visits for FeNO monitoring and duration of effect.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-6\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Limitations of the evidence base impose considerable uncertainty on all analyses. Equivalence of devices was assumed but not assured. Evidence for diagnosis is difficult to interpret in the context of inserting FeNO monitoring into a diagnostic pathway. Evidence for management is also inconclusive, but largely consistent with FeNO monitoring resulting in fewer exacerbations, with a small or zero reduction in ICS use in adults and a possible increased ICS use in children or patients with more severe asthma. It is unclear which specific management protocol is likely to be most effective. The economic analysis indicates that FeNO monitoring could have value in diagnostic and management settings. The diagnostic model indicates that FeNO monitoring plus bronchodilator reversibility dominates many other diagnostic tests. FeNO-guided management has the potential to be cost-effective, although this is largely dependent on the duration of effect. The conclusions drawn from both models require strong technical value judgements with respect to several aspects of the decision problem in which little or no empirical evidence exists. There are many potential directions for further work, including investigations into which management protocol is best and long-term follow-up in both diagnosis and management studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-7\">\n                    <jats:title>Study registration<\/jats:title>\n                    <jats:p>This study is registered as PROSPERO CRD42013004149.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-8\">\n                    <jats:title>Funding<\/jats:title>\n                    <jats:p>The National Institute for Health Research Health Technology Assessment programme.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3310\/hta19820","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T00:48:06Z","timestamp":1445474886000},"page":"1-330","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":61,"title":["Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NObreath"],"prefix":"10.3310","volume":"19","author":[{"given":"Sue E","family":"Harnan","sequence":"first","affiliation":[{"name":"School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Tappenden","sequence":"additional","affiliation":[{"name":"School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munira","family":"Essat","sequence":"additional","affiliation":[{"name":"School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Gomersall","sequence":"additional","affiliation":[{"name":"School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Minton","sequence":"additional","affiliation":[{"name":"Advanced Quantitative Methods Network (AQMEN), University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Wong","sequence":"additional","affiliation":[{"name":"School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Pavord","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Everard","sequence":"additional","affiliation":[{"name":"School of Paediatrics and Child Health, University of Western Australia, Princess Margaret Hospital, WA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rod","family":"Lawson","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Royal Hallamshire Hospital, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2015,10]]},"reference":[{"key":"key20151020153619892_ref1-bib1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1164\/ajrccm.162.1.9907008","article-title":"Differences in incidence of reported asthma related to age in men and women","volume":"162","author":"de Roberto","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"key20151020153619892_ref1-bib2","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/S0140-6736(02)11679-5","article-title":"Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial","volume":"360","author":"Green","year":"2002","journal-title":"Lancet"},{"key":"key20151020153619892_ref1-bib3","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1258\/0007142001903490","article-title":"Eosinophils in asthma and other allergic diseases","volume":"56","author":"Wardlaw","year":"2000","journal-title":"Br Med Bull"},{"key":"key20151020153619892_ref1-bib4","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1136\/thx.2006.073429","article-title":"Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma","volume":"62","author":"Berry","year":"2007","journal-title":"Thorax"},{"key":"key20151020153619892_ref1-bib5","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/thx.2009.124925","article-title":"Exhaled nitric oxide thresholds associated with a sputum eosinophil count \u2265\u20093% in a cohort of unselected patients with asthma","volume":"65","author":"Schleich","year":"2010","journal-title":"Thorax"},{"key":"key20151020153619892_ref1-bib6","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S0140-6736(08)61421-X","article-title":"Inflammometry to assess airway diseases","volume":"372","author":"Pavord","year":"2008","journal-title":"Lancet"},{"key":"key20151020153619892_ref1-bib7","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1164\/ajrccm\/148.3.713","article-title":"Sudden-onset fatal asthma: a distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa?","volume":"148","author":"Sur","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"key20151020153619892_ref1-bib8","volume-title":"British Guideline on the Management of Asthma: a National Clinical Guideline","author":"British Thoracic Society\/Scottish Intercollegiate Guidelines Network","year":"2012"},{"key":"key20151020153619892_ref1-bib9","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nature Med"},{"key":"key20151020153619892_ref1-bib10","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.2165\/00003495-200262120-00003","article-title":"Exercise-induced bronchoconstriction","volume":"62","author":"Gotshall","year":"2002","journal-title":"Drugs"},{"key":"key20151020153619892_ref1-bib11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/thx.2006.066407","article-title":"50 years of asthma: UK trends from 1955 to 2004","volume":"62","author":"Anderson","year":"2007","journal-title":"Thorax"},{"key":"key20151020153619892_ref1-bib12","volume-title":"Health Survey for England 2010: Volume 1. Chapter 2: Respiratory Symptoms and Disease in Adults","author":"Hall","year":"2011"},{"issue":"19","key":"key20151020153619892_ref1-bib13","doi-asserted-by":"publisher","DOI":"10.3310\/hta12190","article-title":"Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over","volume":"12","author":"Shepherd","year":"2008","journal-title":"Health Technol Assess"},{"key":"key20151020153619892_ref1-bib14","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1136\/thx.54.11.985","article-title":"A confidential inquiry into asthma deaths in Wales","volume":"54","author":"Burr","year":"1999","journal-title":"Thorax"},{"key":"key20151020153619892_ref1-bib15","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1136\/thx.54.11.978","article-title":"Scottish Confidential Inquiry into Asthma Deaths (SCIAD), 1994\u20136","volume":"54","author":"Bucknall","year":"1999","journal-title":"Thorax"},{"key":"key20151020153619892_ref1-bib16","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1136\/thorax.57.12.1034","article-title":"Psychological, social and health behaviour risk factors for deaths certified as asthma: a national case\u2013control study","volume":"57","author":"Sturdy","year":"2002","journal-title":"Thorax"},{"key":"key20151020153619892_ref1-bib17","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1136\/thx.2004.025593","article-title":"Deaths certified as asthma and use of medical services: a national case\u2013control study","volume":"60","author":"Sturdy","year":"2005","journal-title":"Thorax"},{"key":"key20151020153619892_ref1-bib18","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S0954-6111(99)90061-6","article-title":"A confidential enquiry into certified asthma deaths in the North of England, 1994\u201396: influence of co-morbidity and diagnostic inaccuracy","volume":"93","author":"Jones","year":"1999","journal-title":"Respir Med"},{"key":"key20151020153619892_ref1-bib19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1136\/thx.39.2.131","article-title":"Asthma and irreversible airflow obstruction","volume":"39","author":"Brown","year":"1984","journal-title":"Thorax"},{"key":"key20151020153619892_ref1-bib20","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1056\/NEJM200010123431501","article-title":"Long-term effects of budesonide or nedocromil in children with asthma","volume":"343","author":"Childhood Asthma Management Program Research Group","year":"2000","journal-title":"N Engl J Med"},{"key":"key20151020153619892_ref1-bib21","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1056\/NEJM200010123431502","article-title":"Effect of long-term treatment with inhaled budesonide on adult height in children with asthma","volume":"343","author":"Agertoft","year":"2000","journal-title":"N Engl J Med"},{"key":"key20151020153619892_ref1-bib22","volume-title":"Health Survey for England 2010: Volume 1 \u2013 Respiratory Health","author":"Craig","year":"2011"},{"key":"key20151020153619892_ref1-bib23","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"key20151020153619892_ref1-bib24","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2174\/092986711795328436","article-title":"Exhaled nitric oxide in asthma in adults: the end is the beginning?","volume":"18","author":"Kostikas","year":"2011","journal-title":"Curr Med Chem"},{"key":"key20151020153619892_ref1-bib25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/thx.54.2.108","article-title":"Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma","volume":"54","author":"Jatakanon","year":"1999","journal-title":"Thorax"},{"key":"key20151020153619892_ref1-bib26","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1183\/09031936.02.00285302","article-title":"Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose\u2013response relationship","volume":"20","author":"Jones","year":"2002","journal-title":"Eur Respir J"},{"key":"key20151020153619892_ref1-bib27","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1378\/chest.119.5.1322","article-title":"Dose\u2013response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients","volume":"119","author":"Silkoff","year":"2001","journal-title":"Chest"},{"key":"key20151020153619892_ref1-bib28","volume-title":"Stakeholders Comments to NICE","author":"Aerocrine","year":"2013"},{"key":"key20151020153619892_ref1-bib29","volume-title":"Measurement of Exhaled Nitric Oxide Concentration in Asthma; NIOX MINO and NObreath. Final Scope","author":"National Institute for Health and Care Excellence","year":"2013"},{"key":"key20151020153619892_ref1-bib30","volume-title":"Measurement of Exhaled Nitric Oxide Concentration in Asthma: NIOX MINO and NObreath","author":"Minton"},{"key":"key20151020153619892_ref1-bib31","doi-asserted-by":"publisher","first-page":"CD006340","DOI":"10.1002\/14651858.cd006340.pub3","article-title":"Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults","volume":"4","author":"Petsky","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"key20151020153619892_ref1-bib32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.prrv.2011.11.002","article-title":"Childhood asthma management guided by repeated FeNO measurements: a meta-analysis","volume":"13","author":"Jartti","year":"2012","journal-title":"Paediatr Respir Rev"},{"key":"key20151020153619892_ref1-bib33","doi-asserted-by":"publisher","first-page":"AB194","DOI":"10.1016\/j.jaci.2012.12.1362","article-title":"Meta analysis of asthma exacerbation rates in pediatric studies during asthma managed using fractional exhaled nitric oxide versus standard clinical parameters","volume":"131","author":"Spahn","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"key20151020153619892_ref1-bib34","volume-title":"Clinical Guideline Development Methods","author":"National Institute for Health and Care Excellence","year":"2012"},{"key":"key20151020153619892_ref1-bib35","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","article-title":"ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide","volume":"171","author":"American Thoracic Society, European Respiratory Society","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"key20151020153619892_ref1-bib36","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. [updated March 2011]","author":"Higgins","year":"2011"},{"key":"key20151020153619892_ref1-bib37","volume-title":"Systematic Reviews \u2013 CRD\u2019s Guidance for Undertaking Reviews in Healthcare","author":"Centre for Reviews and Dissemination","year":"2009"},{"key":"key20151020153619892_ref1-bib38","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"key20151020153619892_ref1-bib39","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1378\/chest.06-1335","article-title":"Portable exhaled nitric oxide measurement: comparison with the \u2018gold standard\u2019 technique","volume":"131","author":"Menzies","year":"2007","journal-title":"Chest"},{"key":"key20151020153619892_ref1-bib40","doi-asserted-by":"publisher","first-page":"37027","DOI":"10.1088\/1752-7155\/2\/3\/037027","article-title":"A technical report on exhaled nitric oxide measurement: asthma monitoring in athletes","volume":"2","author":"Grob","year":"2008","journal-title":"J Breath Res"},{"key":"key20151020153619892_ref1-bib41","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/j.1440-1843.2010.01847.x","article-title":"Measurement of exhaled nitric oxide: comparison of different analysers","volume":"15","author":"Korn","year":"2010","journal-title":"Respirology"},{"key":"key20151020153619892_ref1-bib42","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1398-9995.2007.01334.x","article-title":"Niox and Niox Mino: comparison of exhaled NO in grass pollen allergic adult volunteers","volume":"62","author":"Chen","year":"2007","journal-title":"Allergy"},{"key":"key20151020153619892_ref1-bib43","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10877-005-1158-z","article-title":"Novel hand-held device for exhaled nitric oxide-analysis in research and clinical applications","volume":"18","author":"Hemmingsson","year":"2004","journal-title":"J Clin Monit Comput"},{"key":"key20151020153619892_ref1-bib44","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.rmed.2008.04.006","article-title":"Exhaled nitric oxide measurements: correction equation to compare hand-held device to stationary analyzer","volume":"102","author":"Pizzimenti","year":"2008","journal-title":"Respir Med"},{"key":"key20151020153619892_ref1-bib45","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1111\/j.1398-9995.2007.01475.x","article-title":"Reliability of a new hand-held device for the measurement of exhaled nitric oxide","volume":"62","author":"Khalili","year":"2007","journal-title":"Allergy"},{"key":"key20151020153619892_ref1-bib46","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1465-9921-7-67","article-title":"Performance of a new hand-held device for exhaled nitric oxide measurement in adults and children","volume":"7","author":"Alving","year":"2006","journal-title":"Respir Res"},{"key":"key20151020153619892_ref1-bib47","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.jaci.2006.03.018","article-title":"Daily home measurements of exhaled nitric oxide in asthmatic children during natural birch pollen exposure","volume":"117","author":"Vahlkvist","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"key20151020153619892_ref1-bib48","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/ppul.20491","article-title":"Validation of a hand-held exhaled nitric oxide analyzer for use in children","volume":"41","author":"McGill","year":"2006","journal-title":"Pediatr Pulmonol"},{"key":"key20151020153619892_ref1-bib49","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/ppul.21390","article-title":"Can we use portable nitric oxide analyzer in young children?","volume":"46","author":"Kalliola","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"key20151020153619892_ref1-bib50","first-page":"105","article-title":"Reliability of the hand-held NIOX MINO device for monitoring asthma control","volume":"24","author":"Ozier","year":"2010","journal-title":"Fund Clin Pharmacol"},{"key":"key20151020153619892_ref1-bib51","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.rmed.2011.01.006","article-title":"Control maintenance can be predicted by exhaled NO monitoring in asthmatic patients","volume":"105","author":"Ozier","year":"2011","journal-title":"Respir Med"},{"key":"key20151020153619892_ref1-bib52","first-page":"791s","article-title":"Determination of exhaled nitric oxide in healthy volunteers and asthmatic patients \u2013 comparison of two devices","volume":"28","author":"Fortuna","year":"2006","journal-title":"Eur Respir J"},{"key":"key20151020153619892_ref1-bib53","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1579-2129(07)60044-5","article-title":"Measurement of fraction of exhaled nitric oxide with the portable NIOX-MINO monitor in healthy adults","volume":"43","author":"Fortuna","year":"2007","journal-title":"Arch Bronconeumol"},{"key":"key20151020153619892_ref1-bib54","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.anai.2011.09.002","article-title":"Validation study of asthma screening criteria based on subjective symptoms and fractional exhaled nitric oxide","volume":"107","author":"Fukuhara","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"key20151020153619892_ref1-bib55","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/j.1440-1843.2012.02163.x","article-title":"Comparison of two exhaled nitric oxide analyzers: the NIOX MINO hand-held electrochemical analyzer and the NOA280i stationary chemiluminescence analyzer","volume":"17","author":"Kim","year":"2012","journal-title":"Respirol"},{"key":"key20151020153619892_ref1-bib56","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1440-1843.2012.02163.x","article-title":"Measurement of exhaled nitric oxide: comparison of two analyzers","volume":"66","author":"Yoon","year":"2011","journal-title":"Allergy"},{"key":"key20151020153619892_ref1-bib57","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.pupt.2008.04.006","article-title":"Exhaled nitric oxide monitoring in COPD using a portable analyzer","volume":"21","author":"de Laurentiis","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"key":"key20151020153619892_ref1-bib58","first-page":"365s","article-title":"Exhaled nitric oxide measured by using NIOX MINO and chemo-luminesence analyser: a comparative study","volume":"30","author":"Peche","year":"2007","journal-title":"Eur Respir J"},{"key":"key20151020153619892_ref1-bib59","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1183\/09031936.00025308","article-title":"Comparisons between portable and chemoluminescence exhaled nitric oxide measurements","volume":"32","author":"Michils","year":"2008","journal-title":"Eur Respir J"},{"key":"key20151020153619892_ref1-bib60","volume-title":"Benchmark Testing Report. Comparison Testing Carried Out by Logan Fesearch Ltd for Bedfont Scientific Ltd \u2013 Reference the NObreath Nitric Oxide Monitoring Product","author":"Logan Research Ltd","year":"2009"},{"key":"key20151020153619892_ref1-bib61","doi-asserted-by":"publisher","first-page":"AB62","DOI":"10.1016\/j.jaci.2010.12.258","volume":"127","author":"Park","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"key20151020153619892_ref1-bib62","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1399-3038.2009.00853.x","article-title":"Comparability of a hand-held nitric oxide analyser with online and offline chemiluminescence-based nitric oxide measurement","volume":"20","author":"Schiller","year":"2009","journal-title":"Pediatr Allergy Immunol"},{"key":"key20151020153619892_ref1-bib63","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1080\/02770900802312582","article-title":"Analysis of single-breath profiles of exhaled nitric oxide in children with allergy and asthma: guideline-derived plateau concentrations compared to results of automatic evaluation by two analyzers","volume":"45","author":"Chladkova","year":"2008","journal-title":"J Asthma"},{"key":"key20151020153619892_ref1-bib64","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.rmed.2008.06.021","article-title":"Comparison of exhaled nitric oxide measurements between Niox Mino electrochemical and Ecomedics chemiluminescence analyzer","volume":"102","author":"Boot","year":"2008","journal-title":"Respir Med"},{"key":"key20151020153619892_ref1-bib65","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3109\/02770903.2010.485667","article-title":"Measurement of fractional exhaled nitric oxide by a new portable device: comparison with the standard technique","volume":"47","author":"Pisi","year":"2010","journal-title":"J Asthma"},{"key":"key20151020153619892_ref1-bib66","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.rmed.2010.06.005","article-title":"Assessment of exhaled nitric oxide by a new hand-held device","volume":"104","author":"Antus","year":"2010","journal-title":"Respir Med"},{"key":"key20151020153619892_ref1-bib67","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ppul.21591","article-title":"Comparative repeatability of two handheld fractional exhaled nitric oxide monitors","volume":"47","author":"Kapande","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"key20151020153619892_ref1-bib68","doi-asserted-by":"publisher","first-page":"S460","DOI":"10.1002\/ppul.21591","article-title":"Comparative repeatability of two handheld fractional exhaled nitric oxide monitors","volume":"180","author":"Kapande","year":"2011","journal-title":"Ir J Med Sci"},{"key":"key20151020153619892_ref1-bib69","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.rmed.2012.10.003","article-title":"FENO measurement and sputum analysis for diagnosing asthma in clinical practice","volume":"107","author":"Schneider","year":"2013","journal-title":"Respir Med"},{"key":"key20151020153619892_ref1-bib70","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/j.rmed.2007.05.019","article-title":"Diagnostic utility of inflammatory biomarkers in asthma: exhaled nitric oxide and induced sputum eosinophil count","volume":"101","author":"Fortuna","year":"2007","journal-title":"Respir Med"},{"key":"key20151020153619892_ref1-bib71","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1465-9921-10-15","article-title":"Diagnosing asthma in general practice with portable exhaled nitric oxide measurement \u2013 results of a prospective diagnostic study","volume":"10","author":"Schneider","year":"2009","journal-title":"Respir Res"},{"key":"key20151020153619892_ref1-bib72","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1465-9921-10-64","article-title":"Diagnosing asthma in general practice with portable exhaled nitric oxide measurement \u2013 results of a prospective diagnostic study: FENO \u2264\u200916\u2009ppb better than FENO \u2264\u200912\u2009ppb to rule out mild and moderate to severe asthma","volume":"10","author":"Schneider","year":"2009","journal-title":"Respir Res"},{"key":"key20151020153619892_ref1-bib73","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jcma.2012.08.010","article-title":"Optimal value of fractional exhaled nitric oxide in inhaled corticosteroid treatment for patients with chronic cough of unknown cause","volume":"76","author":"Hsu","year":"2013","journal-title":"J Chin Med Assoc"},{"key":"key20151020153619892_ref1-bib74","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.4065\/82.11.1350","article-title":"Use of exhaled nitric oxide in predicting response to inhaled corticosteroids for chronic cough","volume":"82","author":"Hahn","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"key20151020153619892_ref1-bib75","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.rmed.2008.04.018","article-title":"Clinical usefulness of fractional exhaled nitric oxide for diagnosing prolonged cough","volume":"102","author":"Sato","year":"2008","journal-title":"Respir Med"},{"key":"key20151020153619892_ref1-bib76","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1378\/chest.08-2942","article-title":"Exhaled nitric oxide measurement is not useful for predicting the response to inhaled corticosteroids in subjects with chronic cough","volume":"136","author":"Prieto","year":"2009","journal-title":"Chest"},{"key":"key20151020153619892_ref1-bib77","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1742-1241.2011.02840.x","article-title":"Is FENO50 useful diagnostic tool in suspected asthma?","volume":"66","author":"Schleich","year":"2012","journal-title":"Int J Clin Pract"},{"key":"key20151020153619892_ref1-bib78","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1378\/chest.124.2.639","article-title":"Exhaled nitric oxide as a predictor of exercise-induced bronchoconstriction","volume":"124","author":"El Halawani","year":"2003","journal-title":"Chest"},{"key":"key20151020153619892_ref1-bib79","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2500\/aap.2006.27.2904","article-title":"Exhaled nitric oxide levels in military recruits with new onset asthma","volume":"27","author":"Arora","year":"2006","journal-title":"Allergy Asthma Proc"},{"key":"key20151020153619892_ref1-bib80","first-page":"P1273","article-title":"Validity of the fractional exhaled nitric oxide (FENO) for identification of bronchial hyperresponsiveness in a pulmonary function laboratory","volume":"42","author":"Chancafe-Morgan","year":"2013","journal-title":"Eur Respir J"},{"key":"key20151020153619892_ref1-bib81","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000350221","article-title":"Exhaled nitric oxide as screening tool in subjects with suspected asthma without reversibility","volume":"162","author":"Katsoulis","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"key20151020153619892_ref1-bib82","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/j.rmed.2006.02.019","article-title":"Exhaled nitric oxide as a diagnostic test for asthma in rhinitic patients with asthmatic symptoms","volume":"100","author":"Heffler","year":"2006","journal-title":"Respir Med"},{"key":"key20151020153619892_ref1-bib83","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1164\/rccm.200411-1498OC","article-title":"Exhaled nitric oxide: a predictor of steroid response","volume":"172","author":"Smith","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"key20151020153619892_ref1-bib84","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.rmed.2011.06.001","article-title":"Predicted versus absolute values in the application of exhaled nitric oxide measurements","volume":"105","author":"de la Barra","year":"2011","journal-title":"Respir Med"},{"key":"key20151020153619892_ref1-bib85","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3109\/02770903.2010.491147","article-title":"Usefulness of exhaled nitric oxide for diagnosing asthma","volume":"47","author":"Pedrosa","year":"2010","journal-title":"J Asthma"},{"key":"key20151020153619892_ref1-bib86","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1164\/rccm.200310-1376OC","article-title":"Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests","volume":"169","author":"Smith","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"key20151020153619892_ref1-bib87","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2500\/aap.2011.32.3419","article-title":"Utility of nitric oxide for the diagnosis of asthma in an allergy clinic population","volume":"32","author":"Cordeiro","year":"2011","journal-title":"Allergy Asthma Proc"},{"key":"key20151020153619892_ref1-bib88","doi-asserted-by":"publisher","first-page":"AB3","DOI":"10.1016\/j.jaci.2011.12.870","article-title":"Is methacholine challenge sufficient to rule out bronchial hyperresponsiveness in patients with suspected asthma?","volume":"129","author":"Bobolea","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"key20151020153619892_ref1-bib89","first-page":"1254","article-title":"Values of fractional exhaled nitric oxide in the diagnosis of chronic cough","volume":"91","author":"Zhang","year":"2011","journal-title":"Chung-Hua i Hsueh Tsa Chih"},{"key":"key20151020153619892_ref1-bib90","first-page":"395","article-title":"Usefulness of exhaled nitric oxide (FeNO) measured by a portable analyzer to diagnose cough variant asthma in a clinical setting of chronic cough","volume":"64","author":"Pizzimenti","year":"2009","journal-title":"Allergy"},{"key":"key20151020153619892_ref1-bib91","article-title":"Relationship between exhaled nitric oxide and methacholine challenge test in suspected asthma","volume":"183","author":"Mathew","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"key20151020153619892_ref1-bib92","first-page":"43","article-title":"Fraction exhaled NO in patients referred to pulmonary function laboratory (PFLAB) for mannitol challenge","volume":"18","author":"Brannan","year":"2013","journal-title":"Respirology"},{"key":"key20151020153619892_ref1-bib93","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1399-3038.2011.01223.x","article-title":"Relation of bronchial and alveolar nitric oxide to exercise-induced bronchoconstriction in atopic children and adolescents","volume":"23","author":"Linkosalo","year":"2012","journal-title":"Pediatr Allergy Immunol"},{"key":"key20151020153619892_ref1-bib94","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/02770900801890273","article-title":"The value of exhaled nitric oxide in predicting bronchial hyperresponsiveness in children","volume":"45","author":"Ramser","year":"2008","journal-title":"J Asthma"},{"key":"key20151020153619892_ref1-bib95","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jpeds.2009.02.034","article-title":"The use of exhaled nitric oxide in the diagnosis of asthma in school children","volume":"155","author":"Sivan","year":"2009","journal-title":"J Pediatr"},{"key":"key20151020153619892_ref1-bib96","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.rmed.2012.03.022","article-title":"Utility of fractional exhaled nitric oxide (FENO) measurements in diagnosing asthma","volume":"106","author":"Woo","year":"2012","journal-title":"Respir Med"},{"key":"key20151020153619892_ref1-bib97","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1056\/NEJMoa043596","article-title":"Use of exhaled nitric oxide measurements to guide treatment in chronic asthma","volume":"352","author":"Smith","year":"2005","journal-title":"N Engl J Med"},{"key":"key20151020153619892_ref1-bib98","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1164\/rccm.200610-1427OC","article-title":"The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial","volume":"176","author":"Shaw","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"key20151020153619892_ref1-bib99","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jaip.2013.07.013","article-title":"Anti-inflammatory treatment of atopic asthma guided by exhaled nitric oxide: a randomized controlled trial","volume":"1","author":"Syk","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"key20151020153619892_ref1-bib100","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1001\/2012.jama.10893","article-title":"Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial","volume":"308","author":"Calhoun","year":"2012","journal-title":"JAMA"},{"key":"key20151020153619892_ref1-bib101","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.jaci.2014.07.016","article-title":"A cluster randomized trial comparing strict, partial, and FeNO-guided asthma control strategies in primary care","volume":"42","author":"Honkoop","year":"2013","journal-title":"Eur Respir J"},{"key":"key20151020153619892_ref1-bib102","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(11)60971-9","article-title":"Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial","volume":"378","author":"Powell","year":"2011","journal-title":"Lancet"},{"key":"key20151020153619892_ref1-bib103","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/ppul.20455","article-title":"Exhaled nitric oxide in the management of childhood asthma: a prospective 6-months study","volume":"41","author":"Fritsch","year":"2006","journal-title":"Pediatr Pulmonol"},{"key":"key20151020153619892_ref1-bib104","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S0140-6736(08)61448-8","article-title":"Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial","volume":"372","author":"Szefler","year":"2008","journal-title":"Lancet"},{"key":"key20151020153619892_ref1-bib105","doi-asserted-by":"publisher","first-page":"691425","DOI":"10.1155\/2010\/691425","article-title":"FeNO as a marker of airways inflammation: the possible implications in childhood asthma management","volume":"2010","author":"Verini","year":"2010","journal-title":"J Allergy"},{"key":"key20151020153619892_ref1-bib106","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1164\/rccm.200503-458OC","article-title":"Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial","volume":"172","author":"Pijnenburg","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"key20151020153619892_ref1-bib107","doi-asserted-by":"publisher","first-page":"A3928","DOI":"10.1164\/ajrccm-conference.2010.181.1_meetingabstracts.a3928","article-title":"Dual-center randomised trial on tailored asthma therapy based on exhaled nitric oxide (FENO) versus routine clinical care","volume":"181","author":"Petsky","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"key20151020153619892_ref1-bib108","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1752-699X.2012.00306.x","article-title":"Exhaled nitric oxide monitoring does not reduce exacerbation frequency or inhaled corticosteroid dose in paediatric asthma: a randomised controlled trial","volume":"7","author":"Pike","year":"2013","journal-title":"Clin Respir J"},{"key":"key20151020153619892_ref1-bib109","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.22873","article-title":"Exhaled nitric oxide in childhood allergic asthma management: a randomised controlled trial [published online ahead of print September 4 2013]","author":"Peirsman","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"key20151020153619892_ref1-bib110","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.rmed.2012.02.009","article-title":"The value of exhaled nitric oxide to identify asthma in smoking patients with asthma-like symptoms","volume":"106","author":"Malinovschi","year":"2012","journal-title":"Respir Med"},{"key":"key20151020153619892_ref1-bib111","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1465-9921-12-65","article-title":"Exhaled nitric oxide and clinical phenotypes of childhood asthma","volume":"12","author":"Mahut","year":"2011","journal-title":"Respir Res"},{"key":"key20151020153619892_ref1-bib112","doi-asserted-by":"publisher","first-page":"A22","DOI":"10.1016\/j.anai.2013.07.020","article-title":"Ambulatory fractional exhaled nitric oxide (FENO) measurement in children 4\u20137 years of age","volume":"109","author":"Hanson","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"key20151020153619892_ref1-bib113","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3109\/02770903.2012.701363","article-title":"Relationship between exhaled nitric oxide and exposure to low-level environmental tobacco smoke in children with asthma on inhaled corticosteroids","volume":"49","author":"de la Riva-Velasco","year":"2012","journal-title":"J Asthma"},{"key":"key20151020153619892_ref1-bib114","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1080\/02770900903090004","article-title":"Exhaled nitric oxide in pregnant healthy and asthmatic women","volume":"46","author":"Tamasi","year":"2009","journal-title":"J Asthma"},{"key":"key20151020153619892_ref1-bib115","doi-asserted-by":"publisher","first-page":"A53","DOI":"10.1111\/crj.12017","article-title":"Exhaled nitric oxide is not a marker of eosinophilic inflammation in older Australians","volume":"15","author":"Simpson","year":"2010","journal-title":"Respirology"},{"key":"key20151020153619892_ref1-bib116","doi-asserted-by":"publisher","first-page":"A5096","DOI":"10.1164\/ajrccm-conference.2010.181.1_meetingabstracts.a5096","article-title":"Pathophysiological characteristics of asthma in the elderly","volume":"181","author":"Inoue","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"key20151020153619892_ref1-bib117","doi-asserted-by":"publisher","first-page":"AB8","DOI":"10.1016\/j.jaci.2011.12.891","article-title":"Asthma in the elderly: the role of exhaled nitric oxide measurements","volume":"129","author":"Columbo","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"key20151020153619892_ref1-bib118","doi-asserted-by":"publisher","first-page":"S160","DOI":"10.1097\/01.WOX.0000412212.37057.12","article-title":"Usefulness of asthma control test questionnaire, FEV1 and exhaled nitric oxide level (FENO) for the clinical assessment of elderly asthma","volume":"5","author":"Roh","year":"2012","journal-title":"World Allergy Organ J"},{"key":"key20151020153619892_ref1-bib119","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.anai.2012.02.022","article-title":"Asthma in the elderly: risk factors and impact on physical function","volume":"108","author":"Smith","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"key20151020153619892_ref1-bib120","doi-asserted-by":"publisher","first-page":"A5","DOI":"10.1016\/j.jaip.2012.12.003","article-title":"Factors associated with asthma quality of life and control among older adults","volume":"107","author":"Ross","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"key20151020153619892_ref1-bib121","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1183\/09031936.00154008","article-title":"Exhaled nitric oxide as a marker of asthma control in smoking patients","volume":"33","author":"Michils","year":"2009","journal-title":"Eur Respir J"},{"key":"key20151020153619892_ref1-bib122","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.rmed.2010.10.015","article-title":"Exhaled NO and exhaled breath condensate pH in the evaluation of asthma control","volume":"105","author":"Kostikas","year":"2011","journal-title":"Respir Med"},{"key":"key20151020153619892_ref1-bib123","first-page":"461","article-title":"Exhaled nitric oxide in assessing of asthma control in smoking patients pilot study","volume":"67","author":"Hromis","year":"2012","journal-title":"Allergy"},{"key":"key20151020153619892_ref1-bib124","first-page":"29","article-title":"The effect of better asthma control in pregnancy on wheezy illnesses in infancy","volume":"18","author":"Mattes","year":"2013","journal-title":"Respirology"},{"key":"key20151020153619892_ref1-bib125","doi-asserted-by":"publisher","first-page":"689782","DOI":"10.1155\/2013\/689782","article-title":"Characteristics of atopic bronchial asthma in seniors over 80 years of age","volume":"2013","author":"Bozek","year":"2013","journal-title":"Biomed Res Int"},{"key":"key20151020153619892_ref1-bib126","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.rmed.2013.01.018","article-title":"Asthma in the elderly: the role of exhaled nitric oxide measurements","volume":"107","author":"Columbo","year":"2013","journal-title":"Respir Med"},{"key":"key20151020153619892_ref1-bib127","first-page":"322","article-title":"Measurements of fractional exhaled nitric oxide with 2 portable electrochemical sensors: a comparative study","volume":"21","author":"Olaguibel","year":"2011","journal-title":"J Investig Allergol Clin Immunol"},{"key":"key20151020153619892_ref1-bib128","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"327","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"key20151020153619892_ref1-bib129","volume-title":"Global Strategy for Asthma Management and Prevention","author":"Global Initiative for Asthma","year":"2007"},{"key":"key20151020153619892_ref1-bib130","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1164\/ajrccm\/136.1.225","article-title":"Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma","volume":"136","author":"American Thoracic Society","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"key20151020153619892_ref1-bib131","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2288-3-25","article-title":"The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews","volume":"3","author":"Whiting","year":"2003","journal-title":"BMC Med Res Methodol"},{"key":"key20151020153619892_ref1-bib132","doi-asserted-by":"crossref","first-page":"483e91","DOI":"10.1183\/09031936.95.08030483","article-title":"International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods","volume":"8","author":"Asher","year":"1995","journal-title":"Eur Respir J"},{"key":"key20151020153619892_ref1-bib133","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1164\/ajrccm.160.6.ats8-99","article-title":"American Thoracic Society. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children \u2013 1999","volume":"160","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"key20151020153619892_ref1-bib134","volume-title":"Report 3: Guidelines for the Diagnosis and Management of Asthma","author":"National Asthma Education and Prevention Program Expert Panel","year":"2007"},{"key":"key20151020153619892_ref1-bib135","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","journal-title":"Eur Respir J"},{"key":"key20151020153619892_ref1-bib136","volume-title":"Global Strategy for Asthma Management and Prevention","author":"Global Initiative for Asthma","year":"2002"},{"key":"key20151020153619892_ref1-bib137","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"key20151020153619892_ref1-bib138","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1136\/thx.2009.125443","article-title":"Influence of atopy and asthma on exhaled nitric oxide in an unselected birth cohort study","volume":"65","author":"Scott","year":"2010","journal-title":"Thorax"},{"key":"key20151020153619892_ref1-bib139","first-page":"900","article-title":"Consensus guidelines for drug therapy of bronchial asthma in children and adolescents","volume":"111","author":"Frischer","year":"1999","journal-title":"Wien Klin Wochenschr"},{"key":"key20151020153619892_ref1-bib140","author":"National Heart, Lung, and Blood Institute (NHLBI)","year":"2013","journal-title":"National Asthma Education and Prevention Program"},{"key":"key20151020153619892_ref1-bib141","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1183\/09031936.02.01582001","article-title":"Changes of exhaled nitric oxide during steroid treatment of childhood asthma","volume":"19","author":"Beck-Ripp","year":"2002","journal-title":"Eur Respir J"},{"key":"key20151020153619892_ref1-bib142","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3109\/07853890008995949","article-title":"Increased bronchial nitric oxide production in patients with asthma measured with a novel method of different exhalation flow rates","volume":"32","author":"Lehtimaki","year":"2000","journal-title":"Ann Med"},{"key":"key20151020153619892_ref1-bib143","volume-title":"Asthma: Long-Acting Beta 2 Agonists: Reminder for Use in Children and Adults","author":"Medicines and Healthcare products Regulatory Agency"},{"key":"key20151020153619892_ref1-bib144","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198529446.001.0001","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2005"},{"key":"key20151020153619892_ref1-bib145","volume-title":"Diagnostics Assessment Programme Manual","author":"National Institute for Health and Care Excellence","year":"2011"},{"key":"key20151020153619892_ref1-bib146","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1524-4733.2003.00234.x","article-title":"Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices \u2013 Modeling Studies","volume":"6","author":"Weinstein","year":"2003","journal-title":"Value Health"},{"key":"key20151020153619892_ref1-bib147","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1398-9995.2008.01855.x","article-title":"An economic evaluation of NIOX MINO airway inflammation monitor in the United Kingdom","volume":"64","author":"Price","year":"2009","journal-title":"Allergy"},{"key":"key20151020153619892_ref1-bib148","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.rmed.2007.09.008","article-title":"Economic evaluation of FE(NO) measurement in diagnosis and 1-year management of asthma in Germany","volume":"102","author":"Berg","year":"2008","journal-title":"Respir Med"},{"issue":"5","key":"key20151020153619892_ref1-bib149","doi-asserted-by":"publisher","DOI":"10.3310\/hta6050","article-title":"The clinical effectiveness and cost-effectiveness of inhaler devices used in the routine management of chronic asthma in older children: a systematic review and economic evaluation","volume":"6","author":"Peters","year":"2002","journal-title":"Health Technol Assess"},{"key":"key20151020153619892_ref1-bib150","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1398-9995.2006.01038.x","article-title":"Cost-effectiveness of asthma control: an economic appraisal of the GOAL study","volume":"61","author":"Briggs","year":"2006","journal-title":"Allergy"},{"key":"key20151020153619892_ref1-bib151","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1185\/030079907X187982","article-title":"Cost-effectiveness of salmeterol xinafoate\/fluticasone propionate combination inhaler in chronic asthma","volume":"23","author":"Doull","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"key20151020153619892_ref1-bib152","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2165\/11537550-000000000-00000","article-title":"Cost-effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial","volume":"28","author":"Wilson","year":"2010","journal-title":"Pharmacoeconomics"},{"key":"key20151020153619892_ref1-bib153","doi-asserted-by":"publisher","first-page":"A493","DOI":"10.1016\/j.jval.2011.08.1423","article-title":"The cost-effectiveness of step down from high dose ICS\/LABA combination therapy in asthma in the UK setting","volume":"14","author":"Paggiaro","year":"2011","journal-title":"Value Health"},{"key":"key20151020153619892_ref1-bib154","first-page":"65","article-title":"A comparison of the cost-effectiveness of alternative prophylactic therapies in the treatment of adult asthma","volume":"8","author":"Booth","year":"1995","journal-title":"Br J Med Econ"},{"key":"key20151020153619892_ref1-bib155","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1053\/rmed.1999.0577","article-title":"The cost-effectiveness of inhaled fluticasone propionate and budesonide in the treatment of asthma in adults and children","volume":"93","author":"Barnes","year":"1999","journal-title":"Respir Med"},{"key":"key20151020153619892_ref1-bib156","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1136\/thx.2003.017244","article-title":"Airway inflammation in children with difficult asthma: relationships with airflow limitation and persistent symptoms","volume":"59","author":"Payne","year":"2004","journal-title":"Thorax"},{"key":"key20151020153619892_ref1-bib157","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1053\/rmed.2001.1258","article-title":"Cost-effectiveness of eformoterol Turbohaler versus salmeterol Accuhaler in children with symptomatic asthma","volume":"96","author":"Everden","year":"2002","journal-title":"Respir Med"},{"key":"key20151020153619892_ref1-bib158","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2165\/00019053-200220030-00004","article-title":"Development of an economic model to assess the cost-effectiveness of asthma management strategies","volume":"20","author":"Price","year":"2002","journal-title":"Pharmacoeconomics"},{"key":"key20151020153619892_ref1-bib159","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1183\/09031936.04.00108703","article-title":"Country-specific cost-effectiveness of early intervention with budesonide in mild asthma","volume":"24","author":"Buxton","year":"2004","journal-title":"Eur Respir J"},{"key":"key20151020153619892_ref1-bib160","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/j.1398-9995.2007.01466.x","article-title":"Cost-effectiveness of budesonide\/formoterol for maintenance and reliever asthma therapy","volume":"62","author":"Price","year":"2007","journal-title":"Allergy"},{"key":"key20151020153619892_ref1-bib161","first-page":"75","article-title":"Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: a real world observational study","volume":"2","author":"Kemp","year":"2010","journal-title":"Clinicoecon Outcomes Res"},{"key":"key20151020153619892_ref1-bib162","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00130832-200502000-00010","article-title":"Is exhaled nitric oxide measurement a useful clinical test in asthma?","volume":"5","author":"Smith","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"key20151020153619892_ref1-bib163","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1378\/chest.121.4.1051","article-title":"A comparison of the validity of different diagnostic tests in adults with asthma","volume":"121","author":"Hunter","year":"2002","journal-title":"Chest"},{"key":"key20151020153619892_ref1-bib164","volume-title":"British Guideline on the Management of Asthma, 2007 update","author":"British Thoracic Society and Scottish Intercollegiate Guidelines Network","year":"2007"},{"key":"key20151020153619892_ref1-bib165","volume-title":"NHS Reference Costs 2005","author":"Department of Health","year":"2005"},{"key":"key20151020153619892_ref1-bib166","volume-title":"Unit Costs of Health and Social Care 2005","author":"Curtis","year":"2005"},{"key":"key20151020153619892_ref1-bib167","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2006","edition":"51 ed."},{"key":"key20151020153619892_ref1-bib168","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1378\/chest.123.3.751","article-title":"Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma","volume":"123","author":"Dupont","year":"2003","journal-title":"Chest"},{"key":"key20151020153619892_ref1-bib169","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1183\/09031936.06.00137704","article-title":"Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations","volume":"27","author":"Jayaram","year":"2006","journal-title":"Eur Respir J"},{"key":"key20151020153619892_ref1-bib170","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1053\/rmed.2001.1078","article-title":"Adding formoterol to budesonide in moderate asthma \u2013 health economic results from the FACET study","volume":"95","author":"Andersson","year":"2001","journal-title":"Respir Med"},{"key":"key20151020153619892_ref1-bib171","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1164\/ajrccm.160.2.9811100","article-title":"Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group","volume":"160","author":"Tattersfield","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"key20151020153619892_ref1-bib172","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2165\/00019053-200422080-00005","article-title":"Psychometric and utility-based measures of health status of asthmatic patients with different disease control level","volume":"22","author":"Szende","year":"2004","journal-title":"Pharmacoeconomics"},{"key":"key20151020153619892_ref1-bib173","volume-title":"Asthma Prevalence, Health Care Use, and Mortality: United States, 2005\u20132009. National Health Statistics Reports","author":"Akinbami","year":"2011"},{"key":"key20151020153619892_ref1-bib174","volume-title":"NHS Reference Costs 2011\u201312","author":"Department of Health","year":"2012"},{"key":"key20151020153619892_ref1-bib175","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/bmj.316.7133.736","article-title":"Variations in population health status: results from a United Kingdom national questionnaire survey","volume":"316","author":"Kind","year":"1998","journal-title":"BMJ"},{"key":"key20151020153619892_ref1-bib176","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/j.1398-9995.2009.02237.x","article-title":"Childhood asthma control test (C-ACT) and nasal eosinophil inflammation in asthmatic children","volume":"65","author":"Piacentini","year":"2010","journal-title":"Allergy"},{"key":"key20151020153619892_ref1-bib177","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1016\/S0091-6749(00)90734-6","article-title":"A high dose of inhaled budesonide is more cost-effective than a low dose in moderate asthma","volume":"105","author":"Andersson","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"key20151020153619892_ref1-bib178","volume-title":"British Guideline on the Management of Asthma","author":"British Thoracic Society\/Scottish Intercollegiate Guidelines Network","year":"2005","edition":"Revised edn."},{"key":"key20151020153619892_ref1-bib179","volume-title":"Unit Costs of Health and Social Care 2012","author":"Curtis","year":"2012"},{"issue":"20","key":"key20151020153619892_ref1-bib180","doi-asserted-by":"publisher","DOI":"10.3310\/hta12200","article-title":"Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years","volume":"12","author":"Main","year":"2008","journal-title":"Health Technol Assess"},{"key":"key20151020153619892_ref1-bib181","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11136-008-9309-6","article-title":"The validity of generic and condition-specific preference-based instruments: the ability to discriminate asthma control status","volume":"17","author":"McTaggart-Cowan","year":"2008","journal-title":"Qual Life Res"},{"key":"key20151020153619892_ref1-bib182","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1177\/0272989X11401031","article-title":"Catalogue of EQ-5D scores for the United Kingdom","volume":"31","author":"Sullivan","year":"2011","journal-title":"Med Decis Making"},{"key":"key20151020153619892_ref1-bib183","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1524-4733.2010.00700.x","article-title":"Populating an economic model with health state utility values: moving toward better practice","volume":"13","author":"Ara","year":"2010","journal-title":"Value Health"},{"key":"key20151020153619892_ref1-bib184","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3132\/pcrj.2007.00002","article-title":"The impact of asthma exacerbations on health-related quality of life in moderate to severe asthma patients in the UK","volume":"16","author":"Lloyd","year":"2007","journal-title":"Prim Care Respir J"},{"key":"key20151020153619892_ref1-bib185","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2013","edition":"65 ed."},{"key":"key20151020153619892_ref1-bib186","volume-title":"A Review of the Psychometric Performance of the EQ-5D in Patients with Asthma","author":"Davis","year":"2010"},{"key":"key20151020153619892_ref1-bib187","volume-title":"Inhaled Corticosteroids for the Treatment of Chronic Asthma in Children under the Age of 12 Years","author":"National Institute for Health and Care Excellence","year":"2007"},{"key":"key20151020153619892_ref1-bib188","volume-title":"Inhaled Corticosteroids for the Treatment of Chronic Asthma in Adults and in Children aged 12 Years and Over","author":"National Institute for Health and Care Excellence","year":"2008"},{"key":"key20151020153619892_ref1-bib189","volume-title":"Interim Life Tables, England and Wales, 2009\u20132011","author":"Office for National Statistics","year":"2011"},{"key":"key20151020153619892_ref1-bib190","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1164\/rccm.200807-1010OC","article-title":"Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma","volume":"179","author":"de Jongste","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"key20151020153619892_ref1-bib191","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.rmed.2013.02.018","article-title":"Exhaled nitric oxide to predict corticosteroid responsiveness and reduce asthma exacerbation rates","volume":"107","author":"Donohue","year":"2013","journal-title":"Respir Med"},{"key":"key20151020153619892_ref1-bib192","doi-asserted-by":"publisher","first-page":"727x","DOI":"10.1016\/S0002-9343(00)00615-X","article-title":"Asthma in pregnancy","volume":"109","author":"Tan","year":"2000","journal-title":"Am J Med"},{"key":"key20151020153619892_ref1-bib193","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLOS Med"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta19820\/hta19820.xml","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2002358","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta19820\/hta19820.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2002768","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T18:39:51Z","timestamp":1718131191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/hta19820\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":193,"journal-issue":{"issue":"82","published-online":{"date-parts":[[2015,10]]}},"alternative-id":["10.3310\/hta19820"],"URL":"https:\/\/doi.org\/10.3310\/hta19820","relation":{},"ISSN":["1366-5278","2046-4924"],"issn-type":[{"value":"1366-5278","type":"print"},{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"}]}}